Submitted:
27 April 2025
Posted:
28 April 2025
Read the latest preprint version here
Abstract
A control group is the usual method for maintaining the integrity of medicine: the first group that received the treatment and the control group that did not. This statistical methodology ensures the integrity of public health policy. The main scientific literature on the effectiveness of the COVID-19 vaccination does not use the unvaccinated part of the population as a control group. This methodological error causes huge negative effects on global public health policy.
Keywords:
1. Introduction
2. Exact Statistical Evaluation of COVID-19 Vaccination Effectiveness
3. Medical Authorities Are Hiding Data on COVID-19 Vaccination Effectiveness
| Number of cancer | 2017 | 2018 | 2019 | 2020 | 2017-2020 | 2021 |
| 15653 | 16778 | 16873 | 15625 | 16232 (100%) |
17349 (116%) |
|
| +1117 (16%) |
4. Hypothetical Evaluations of COVID-19 Vaccine Effectiveness Have No Scientific Validity and Cannot Be the Guide of Public Health Policy

5. COVID-19 Vaccination Changes the Human Genome and Causes Several Diseases, and Should Be Taken off the Market
6. Conclusions
Acknowledgments
References
- Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293-1302 https://pubmed.ncbi.nlm.nih.gov/35753318/. [CrossRef]
- World Health Organization. 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021. 2022. https://www.who.int/news/item/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-covid-19-pandemic-in-2020-and-2021.
- Kislaya I, Machado A, Magalhães S, Rodrigues AP, Franco R, Leite PP, et al. COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: Cohort study based on electronic health records, Portugal, May to July 2022. Euro Surveill. 2022;27(37):2200697. https://pubmed.ncbi.nlm.nih.gov/36111555/.
- Wu N, Joyal-Desmarais K, Ribeiro PA, Vieira AM, Stojanovic Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11(5):439-452. https://pubmed.ncbi.nlm.nih.gov/36780914/.
- Savinkina A, Bilinski A, Fitzpatrick M, Paltiel AD, Rizvi Z, Salomon J, et al. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. BMJ open. 2022;12(9):e061752. https://pubmed.ncbi.nlm.nih.gov/36100306/.
- Šorli AS, Makovec T, Krevel Z, Gorjup R (2023) Forgotten “Primum Non Nocere” and Increased Mortality after COVID-19Vaccination. Qual Prim Care. 31.06. https://www.primescholars.com/articles/forgotten-primum-non-nocere-and-increased-mortality-after--covid19-vaccination.pdf.
- NIJZ – National Institute of Public Health https://nijz.si/en/ (2025).
- Cancer Registry of Republic of Slovenia http://www.slora.si/groba-stopnja (2025).
- Oversight body for the National Health Service in England (NHS) https://www.england.nhs.uk/2024/10/nhs-diagnoses-thousands-more-cancers-as-cases-rise-by-5/ (2025).
- STATISTA https://www.statista.com/statistics/1242449/slovenia-vaccination-against-covid-19-by-date/ (2025).
- Sorli AS (2025). The Discrepancy Between the Number of Saved Lives with COVID-19 Vaccination and Statistics of Our World Data. J Clin Trials. S32:001. https://www.longdom.org/open-access/the-discrepancy-between-the-number-of-saved-lives-with-covid19-vaccination-and-statistics-of-our-world-data.pdf.
- Alessandria M, Malatesta G, Di Palmo G, Cosentino M, Donzelli A. All-cause mortality according to COVID-19 vaccination status: An analysis of the UK Office for National Statistics public data. F1000Res. 2025 Feb 20;13:886. PMID: 40028449; PMCID: PMC11868741. [CrossRef]
- Our World Data (2025) https://ourworldindata.org/coronavirus.
- Makovec T, Šorli AS, Gorjup R, Krevel Z, Piberl S. Analysis of COVID-19 vaccination effectiveness. J Vaccines Vaccin. 2020;14(5):530. https://www.walshmedicalmedia.com/open-access/analysis-of-covid19-vaccination-effectiveness.pdf.
- Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A. 2021 May 25;118(21):e2105968118. https://doi.org/10.1073/pnas.2105968118. PMID: 33958444; PMCID: PMC8166107. https://www.pnas.org/doi/10.1073/pnas.2105968118. [CrossRef]
- Young Mi Lee, Daniel Broudy, Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study, Vol 3 Num 2 IJVTPR (2024) https://www.ijvtpr.com/index.php/IJVTPR/article/view/102/291.
- Mead MN, Seneff S, Wolfinger R, Rose J, Denhaerynck K, Kirsch S, McCullough PA. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. Cureus. 2024 Jan 24;16(1):e52876. https://doi.org/10.7759/cureus.52876. Retraction in: Cureus. 2024 Feb 26;16(2):r137. https://doi.org/10.7759/cureus.r137. PMID: 38274635; PMCID: PMC10810638. https://pubmed.ncbi.nlm.nih.gov/38274635/. [CrossRef]
- M. Nathaniel Mead et.al. ,COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1, IJVTPR (2024) https://ijvtpr.com/index.php/IJVTPR/article/view/101.
- M. Nathaniel Mead et.al. COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 (2024) https://ijvtpr.com/index.php/IJVTPR/article/view/104.
- Kim, H.J., Kim, MH., Choi, M.G. et al. Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea. Mol Psychiatry 29, 3635–3643 (2024). [CrossRef]
- Hazan, Sabine MD1; Dave, Sonya PhD2; Barrows, Brad DO1; Borody, Thomas J. MD, PhD, DSc, FACG3. S2099 Persistent Damage to the Gut Microbiome Following Messenger RNA SARS-CoV-2 Vaccine. The American Journal of Gastroenterology 117(10S):p e1429-e1430, October 2022. |. https://doi.org/10.14309/01.ajg.0000865036.78992.16 https://journals.lww.com/ajg/Fulltext/2022/10002/S2099_Persistent_Damage_to_the_Gut_Microbiome.2099.aspx. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).